Awaiting development: Guidance and quality standards

Showing 51 to 60 of 362

Guidance and quality standards awaiting development
Title	Type
Capivasertib with abiraterone for treating hormone-sensitive metastatic prostate cancer with PTEN deficiency [ID6466]	Technology appraisal guidance
Carfilzomib in combination for untreated multiple myeloma when an autologous stem cell transplant is suitable [TSID12176]	Technology appraisal guidance
Cenobamate for adjunctive treatment of primary generalised tonic-clonic seizures in epilepsy [TSID10214]	Technology appraisal guidance
Clone of IPG190 Insertion of pleuro–amniotic shunt for fetal pleural effusion	HealthTech guidance
CM-AT for behaviours associated with autism in children and young people [ID6731]	Technology appraisal guidance
COLOFIT algorithm to guide colorectal cancer pathway referral in primary care	HealthTech guidance
Concizumab for treating severe haemophilia A or moderate to severe haemophilia B in people 12 years and over without inhibitors [ID5099]	Technology appraisal guidance
Cosibelimab for treating advanced cutaneous squamous cell carcinoma [ID6663]	Technology appraisal guidance
Crovalimab for treating atypical haemolytic uraemic syndrome [TSID12386]	Technology appraisal guidance
Dabigatran etexilate for the secondary prevention of stroke after an embolic stroke of undetermined source [ID1417]	Technology appraisal guidance